Anesticaine
Brand Name: Anesticaine
Generic Name: Bupivacaine Hydrochloride
Active
Registration Number
DRP-12886
Dosage Form
Solution for Injection (for Peripheral Nerve Block, Caudal Block, and Lumbar Epidural Block)
Issuance Date
October 25, 2022
Expiry Date
October 25, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5 mg/mL (0.5% w/v)
Packaging10 mL Type I clear and colorless glass ampoule with break ring or one-point cut, placed in a PVC tray (Box of 5's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Local Anesthetic (Amide)
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Bupivacaine HydrochlorideActive
Monograph: Bupivacaine